# Akanda Corp.: financial statements, quarterly

AKAN · Nasdaq · CIK 1888014 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/akan.md) · [Financials](/companies/akan/financials.md) · [Filings](/companies/akan/filings.md) · [Insiders](/companies/akan/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/akan/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2018-12-31) | period not labelled (2019-12-31) | period not labelled (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001104659-23-054686.md) | [0.8](/filings/0001104659-23-054686.md) | [0.0](/filings/0001104659-23-054686.md) | [3.5](/filings/0001213900-24-038353.md) | [0.3](/filings/0001213900-25-037490.md) | [0.1](/filings/0001213900-25-037490.md) | [3.8](/filings/0001213900-25-037490.md) |
| Current assets | $m | not reported | not reported | [0.1](/filings/0001104659-23-054686.md) | [4.0](/filings/0001104659-23-054686.md) | [3.8](/filings/0001213900-24-038353.md) | [1.8](/filings/0001213900-25-037490.md) | [5.1](/filings/0001213900-25-037490.md) |
| Total assets | $m | not reported | not reported | [4.3](/filings/0001104659-23-054686.md) | [8.0](/filings/0001104659-23-054686.md) | [39.0](/filings/0001213900-24-038353.md) | [8.8](/filings/0001213900-25-037490.md) | [7.9](/filings/0001213900-25-037490.md) |
| Current liabilities | $m | not reported | not reported | [2.7](/filings/0001104659-23-054686.md) | [8.3](/filings/0001104659-23-054686.md) | [9.3](/filings/0001213900-24-038353.md) | [10.2](/filings/0001213900-25-037490.md) | [3.6](/filings/0001213900-25-037490.md) |
| Total liabilities | $m | not reported | not reported | [9.3](/filings/0001104659-23-054686.md) | [10.2](/filings/0001104659-23-054686.md) | [12.1](/filings/0001213900-24-038353.md) | [12.7](/filings/0001213900-25-037490.md) | [3.6](/filings/0001213900-25-037490.md) |
| Shareholders' equity | $m | [(1.5)](/filings/0001104659-23-054686.md) | [(2.9)](/filings/0001104659-23-054686.md) | [(5.0)](/filings/0001104659-23-054686.md) | [(2.2)](/filings/0001213900-24-038353.md) | [26.9](/filings/0001213900-25-037490.md) | [(3.8)](/filings/0001213900-25-037490.md) | [4.3](/filings/0001213900-25-037490.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 1,983,546 at 2025-12-31, from the cover of the [20-F filed 2026-06-09](/filings/0001213900-26-066800.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.